SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mc who wrote (4053)12/26/1997 2:35:00 PM
From: blankmind  Read Replies (1) of 23519
 
-- I don't recall VVUS managment saying anything about a $20 mill drop in cash on the confer call. I do recall them speaking about the huge cash horde, and what could be done with it, but no mention of reducing it by $20 mill. If I'm mistaken, give me a quote & I'll stand corrected.

-- For 1/4 ending 9/30/97, if you go to the statement of changes in cash flow, VVUS spent an additional $10 mill in cash for "property purchases." (note: need to compare 9/30/97 vs. 6/30/97)

-- Yet cash & equivalents still went up by $3 mill.

-- And as silly as it sounds, a reduction in sales can actually bring down your a/r balance and drive up cash. Why? B/c you're collecting on old sales and not racking up new ones. Is this good for business? NO way. However, does it help the cash balance? Yes - at least in the short run.

-- My point is that the cash balance may not be a $100 mill on 12/31/97 - but it won't necessarily be lower - and all indications from a reasonable valuation shows there's no way the balance will drop by $20 mill.

Out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext